KEY FEATURES
| Full Name | Ferritin, Heavy Polypeptide |
|---|---|
| Synonym | FTH1;FHC;FTHL6;PIG15;PLIF;Ferritin Heavy Chain; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 12.5-800ng/mL |
| Sensitivity | 7.5ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human FTH in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human FTH. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human FTH and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human FTH, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human FTH. You can calculate the concentration of Human FTH in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human FTH ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 37.56 | 121.38 | 344.64 | 41.13 | 119.66 | 370.24 |
| Standard deviation | 1.89 | 6.83 | 10.61 | 2.42 | 5.42 | 12.37 |
| CV(%) | 5.02 | 5.63 | 3.08 | 5.88 | 4.53 | 3.34 |
RECOVERY
The recovery of Human FTH spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 92-103 | 97 |
| EDTA plasma (n=8) | 83-95 | 90 |
| Cell culture media (n=8) | 85-100 | 91 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human FTH in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with FE ELISA Kits
| FTL ELISA Kit | publications with FE and FTL |
| TFRC ELISA Kit | publications with FE and TFRC |
| FECH ELISA Kit | publications with FE and FECH |
| ACO1 ELISA Kit | publications with FE and ACO1 |
| MAX ELISA Kit | publications with FE and MAX |
| MYC ELISA Kit | publications with FE and MYC |
Pathways associated with FE ELISA Kit
| Binding And Uptake Of Ligands By Scavenger Receptors Pathway | Binding And Uptake Of Ligands By Scavenger Receptors Pathway |
| Clathrin Derived Vesicle Budding Pathway | Clathrin Derived Vesicle Budding Pathway |
| Golgi Associated Vesicle Biogenesis Pathway | Golgi Associated Vesicle Biogenesis Pathway |
| Iron Metabolism In Placenta Pathway | Iron Metabolism In Placenta Pathway |
| Iron Uptake And Transport Pathway | Iron Uptake And Transport Pathway |
| Membrane Trafficking Pathway | Membrane Trafficking Pathway |
| Mineral Absorption Pathway | Mineral Absorption Pathway |
| Scavenging By Class A Receptors Pathway | Scavenging By Class A Receptors Pathway |
| Transmembrane Transport Of Small Molecules Pathway | Transmembrane Transport Of Small Molecules Pathway |
Diseases associated with FE ELISA Kit
| Inflammation | publications with FE and Inflammation |
| Liver Diseases | publications with FE and Liver Diseases |
| Iron Overload | publications with FE and Iron Overload |
| Disease Models, Animal | publications with FE and Disease Models, Animal |
| Nervous System Diseases | publications with FE and Nervous System Diseases |
| Brain Diseases | publications with FE and Brain Diseases |
| Nerve Degeneration | publications with FE and Nerve Degeneration |
| Neurodegenerative Diseases | publications with FE and Neurodegenerative Diseases |
| Lung Neoplasms | publications with FE and Lung Neoplasms |
| Edema | publications with FE and Edema |
Organs/Tissues associated with FE ELISA Kit
| Blood | publications with FE and Blood |
| Brain | publications with FE and Brain |
| Liver | publications with FE and Liver |
| Nerve | publications with FE and Nerve |
| Placenta | publications with FE and Placenta |
| Bone | publications with FE and Bone |
| Spleen | publications with FE and Spleen |
| Vascular | publications with FE and Vascular |
| Bone Marrow | publications with FE and Bone Marrow |
| Lung | publications with FE and Lung |